Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor

Molecular Biology of the Cell

Volumn 22, Issue 19, 2011, Pages 3725-3733

  Paramasivam, Murugan ^a   Sarkeshik, Ali ^b   Yates III, John R ^b   Fernandes, Maria J G ^c,d   McCollum, Dannel ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c UNIVERSITÉ LAVAL   (Canada)

^d LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LATS2 KINASE; MEMBRANE PROTEIN; MST2 KINASE; PROTEIN AMOTL1; PROTEIN AMOTL2; PROTEIN KINASE; PROTEIN YAP; SCAFFOLD PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CELL DENSITY; CONTACT INHIBITION; CONTROLLED STUDY; ENZYME ACTIVATION; GROWTH INHIBITION; HIPPO PATHWAY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TIGHT JUNCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CARRIER PROTEINS; CELL LINE, TUMOR; CONTACT INHIBITION; HEK293 CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TIGHT JUNCTIONS; TUMOR SUPPRESSOR PROTEINS;

EID: 80053363788     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E11-04-0300     Document Type: Article

References (38)

1. Aase K et al. (2007). Angiomotin regulates endothelial cell migration during embryonic angiogenesis. Genes Dev 21, 2055-2068. (Pubitemid 47267291)
2. Abe Y, Ohsugi M, Haraguchi K, Fujimoto J, Yamamoto T (2006). LATS2-Ajuba complex regulates gamma-tubulin recruitment to centrosomes and spindle organization during mitosis. FEBS Lett 580, 782-788. (Pubitemid 43152297)
3. Aylon Y, Michael D, Shmueli A, Yabuta N, Nojima H, Oren M (2006). A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization. Genes Dev 20, 2687-2700. (Pubitemid 44498379)
4. Bao Y, Sumita K, Kudo T, Withanage K, Nakagawa K, Ikeda M, Ohno K, Wang Y, Hata Y (2009). Roles of mammalian sterile 20-like kinase 2-dependent phosphorylations of Mps one binder 1B in the activation of nuclear Dbf2-related kinases. Genes Cells 14, 1369-1381.
5. Bratt A, Birot O, Sinha I, Veitonmaki N, Aase K, Ernkvist M, Holmgren L (2005). Angiomotin regulates endothelial cell-cell junctions and cell motility. J Biol Chem 280, 34859-34869. (Pubitemid 41504620)
6. Bratt A, Wilson WJ, Troyanovsky B, Aase K, Kessler R, van Meir EG, Holmgren L (2002). Angiomotin belongs to a novel protein family with conserved coiled-coil and PDZ binding domains. Gene 298, 69-77. (Pubitemid 35284264)
7. Chan EH, Nousiainen M, Chalamalasetty RB, Schafer A, Nigg EA, Sillje HH (2005). The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene 24, 2076-2086. (Pubitemid 40516201)
8. Chan SW, Lim CJ, Chong YF, Pobbati AV, Huang C, Hong W (2011). Hippo pathway-independent restriction of TAZ and YAP by angiomotin. J Biol Chem 286, 7018-7026.
9. Cheeseman IM, Desai A (2005). A combined approach for the localization and tandem affinity purification of protein complexes from metazoans. Sci STKE 2005, pl1.
10. Das Thakur M, Feng Y, Jagannathan R, Seppa MJ, Skeath JB, Longmore GD (2010). Ajuba LIM proteins are negative regulators of the Hippo signaling pathway. Curr Biol 20, 657-662.
11. Dong A, Gupta A, Pai RK, Tun M, Lowe AW (2011). The human adenocarcinoma-associated gene, AGR2, induces expression of amphiregulin through Hippo pathway co-activator YAP1 activation. J Biol Chem 124, 267-273.
12. Edgar BA (2006). From cell structure to transcription: Hippo forges a new path. Cell 286, 18301-18310.
13. Ernkvist M, Birot O, Sinha I, Veitonmaki N, Nystrom S, Aase K, Holmgren L (2008). Differential roles of p80- and p130-angiomotin in the switch between migration and stabilization of endothelial cells. Biochim Biophys Acta 1783, 429-437.
14. Gagne V, Moreau J, Plourde M, Lapointe M, Lord M, Gagnon E, Fernandes MJ (2009). Human angiomotin-like 1 associates with an angiomotin protein complex through its coiled-coil domain and induces the remodeling of the actin cytoskeleton. Cell Motil Cytoskeleton 66, 754-768.
15. Halder G, Johnson RL (2011). Hippo signaling: growth control and beyond. Development 138, 9-22.
16. Hao Y, Chun A, Cheung K, Rashidi B, Yang X (2008). Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J Biol Chem 283, 5496-5509.
17. Hirabayashi S, Nakagawa K, Sumita K, Hidaka S, Kawai T, Ikeda M, Kawata A, Ohno K, Hata Y (2008). Threonine 74 of MOB1 is a putative key phosphorylation site by MST2 to form the scaffold to activate nuclear Dbf2-related kinase 1. Oncogene 27, 4281-4292. (Pubitemid 352009997)
18. Hirota T, Morisaki T, Nishiyama Y, Marumoto T, Tada K, Hara T, Masuko N, Inagaki M, Hatakeyama K, Saya H (2000). Zyxin, a regulator of actin filament assembly, targets the mitotic apparatus by interacting with h-warts/LATS1 tumor suppressor. J Cell Biol 149, 1073-1086. (Pubitemid 30354257)
19. Lei QY, Zhang H, Zhao B, Zha ZY, Bai F, Pei XH, Zhao S, Xiong Y, Guan KL (2008). TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the Hippo pathway. Mol Cell Biol 28, 2426-2436. (Pubitemid 351429986)
20. Millward TA, Hess D, Hemmings BA (1999). Ndr protein kinase is regulated by phosphorylation on two conserved sequence motifs. J Biol Chem 274, 33847-33850. (Pubitemid 129511707)
21. Oka T, Mazack V, Sudol M (2008). Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP). J Biol Chem 283, 27534-27546.
22. Oka T et al. (2010). Functional complexes between YAP2 and ZO-2 are PDZ domain-dependent, and regulate YAP2 nuclear localization and signalling. Biochem J 432, 461-472.
23. Overholtzer M, Zhang J, Smolen GA, Muir B, Li W, Sgroi DC, Deng CX, Brugge JS, Haber DA (2006). Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci USA 103, 12405-12410. (Pubitemid 44267272)
24. Patrie KM (2005). Identification and characterization of a novel tight junction-associated family of proteins that interacts with a WW domain of MAGI-1. Biochim Biophys Acta 1745, 131-144.
25. Praskova M, Xia F, Avruch J (2008). MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. Curr Biol 18, 311-321.
26. Ranahan WP, Han Z, Smith-Kinnaman W, Nabinger SC, Heller B, Herbert BS, Chan R, Wells CD (2011). The adaptor protein AMOT promotes the proliferation of mammary epithelial cells via the prolonged activation of the extracellular signal-regulated kinases. Cancer Res 71, 2203-2211.
27. Sugihara-Mizuno Y, Adachi M, Kobayashi Y, Hamazaki Y, Nishimura M, Imai T, Furuse M, Tsukita S (2007). Molecular characterization of angiomotin/ JEAP family proteins: interaction with MUPP1/Patj and their endogenous properties. Genes Cells 12, 473-486. (Pubitemid 46488583)
28. Wang W, Huang J, Chen J (2011). Angiomotin-like proteins associate with and negatively regulate YAP1. J Biol Chem 286, 4364-4370.
29. Xiao L, Chen Y, Ji M, Dong J (2011). KIBRA regulates the Hippo signaling activity via interactions with Lats kinases. J Biol Chem 286, 7788-7796.
30. Yang X, Yu K, Hao Y, Li DM, Stewart R, Insogna KL, Xu T (2004). LATS1 tumour suppressor affects cytokinesis by inhibiting LIMK1. Nat Cell Biol 6, 609-617. (Pubitemid 38960918)
31. Yi C et al. (2011). A tight junction-associated Merlin-angiomotin complex mediates Merlin's regulation of mitogenic signaling and tumor suppressive functions. Cancer Cell 19, 527-540.
32. Zhang J, Ji JY, Yu M, Overholtzer M, Smolen GA, Wang R, Brugge JS, Dyson NJ, Haber DA (2009). YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway. Nat Cell Biol 11, 1444-1450.
33. Zhang J, Smolen GA, Haber DA (2008). Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway. Cancer Res 68, 2789-2794. (Pubitemid 351556277)
34. Zhao B, Lei QY, Guan KL (2008). The Hippo-YAP pathway: new connections between regulation of organ size and cancer. Curr Opin Cell Biol 20, 638-646.
35. Zhao B, Li L, Lu Q, Wang LH, Liu CY, Lei Q, Guan KL (2011). Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev 25, 51-63.
36. Zhao B, Li L, Tumaneng K, Wang CY, Guan KL (2010). A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev 24, 72-85.
37. Zhao B et al. (2007). Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 21, 2747-2761. (Pubitemid 350070721)
38. Zheng Y, Vertuani S, Nystrom S, Audebert S, Meijer I, Tegnebratt T, Borg JP, Uhlen P, Majumdar A, Holmgren L (2009). Angiomotin-like protein 1 controls endothelial polarity and junction stability during sprouting angiogenesis. Circ Res 105, 260-270.